|Articles|April 1, 2000

Asthma Management Alternatives for the New Millennium
Volume 6
Issue 7 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

over 26 years ago

Article

Introduction

over 26 years ago

Article

The 1997 Asthma Guidelines and an Asthma Clinical Update

over 26 years ago

Article

Discussion: Implementing the 1997 Asthma Guidelines

over 26 years ago

Article

Overview of HEDIS 2000 Asthma Measurement

over 26 years ago

Article

Discussion: Using the HEDIS Asthma Measurement

over 26 years ago

Article

Understanding Asthma: Gaps in Knowledge and Their Therapeutic Implications

over 26 years ago

Article

Discussion: The Impact of Allergens on Asthma Severity and Treatment

over 26 years ago

Article

Adjunctive Therapy: Treatment Options

over 26 years ago

Article

Discussion: Treatment Options for Asthma

over 26 years ago

Article

Pharmacoeconomic Impact of Inhaled Corticosteroids

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Participating Faculty

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

5 Notable FDA Approvals From the First Half of 2026

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Participating Faculty

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

5 Notable FDA Approvals From the First Half of 2026

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD